0.854USD+0.854After-hours 07/31, 20:00 (ET)
1.53MMarket Cap
LossP/E TTM
Key Figures
0.860Open
0.860High
19.31KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.08%Turnover Ratio
0.860Prev. Close
0.830Low
11.49KTurnover
LossP/E Static
0.25P/B
0.00%Div Yield TTM
-70.21%ROA
6.75052wk High
0.52Volume Ratio
-7.32MNet Profit
1.80MShares
-1.1558EPS TTM
0.93Beta
-75.40%ROE
1.05052wk Low
3.49%Amplitude
--Gross Margin
1.53MMarket Cap
-9.22Reward/Risk
4.28%Risk Rate
Currency: USD Updated: 2026-07-30 Key Insights
Bone Biologics Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 197 out of 384 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 12.20.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bone Biologics Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Bone Biologics Corp Highlights
StrengthsRisks
Bone Biologics Corp News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bone Biologics Corp Info
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Ticker SymbolBBLG
CompanyBone Biologics Corp
CEOFrelick (Jeffrey)
Websitehttps://www.bonebiologics.com/
Shareholders
FAQs
What is the current price of Bone Biologics Corp (BBLG)?
The current price of Bone Biologics Corp (BBLG) is 0.85.
What is the symbol of Bone Biologics Corp?
The ticker symbol of Bone Biologics Corp is BBLG.
What is the 52-week high of Bone Biologics Corp?
The 52-week high of Bone Biologics Corp is 6.75.
What is the 52-week low of Bone Biologics Corp?
The 52-week low of Bone Biologics Corp is 1.05.
What is the market capitalization of Bone Biologics Corp?
The market capitalization of Bone Biologics Corp is 1.53M.
What is the Earnings Per Share (EPS TTM) of Bone Biologics Corp (BBLG)?
The Earnings Per Share (EPS TTM) of Bone Biologics Corp (BBLG) is -2.65.
